BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Stressgen Biotechnologies Corporation (Canada) 

350-4243 Glanford Avenue

Victoria  British Columbia  V8Z 4B9  Canada
Phone: 250-744-2811 Fax: 250-744-3331


SEARCH JOBS


Industry
Biotechnology






 Company News
Stressgen Biotechnologies Corporation (SSB.TO) Obtains Securityholder Approval For Corporate Transaction 3/17/2006 10:37:44 AM    More...
Stressgen Biotechnologies Corporation (SSB.TO) HspE7 Treatment Showed Higher Than Expected Complete Response Rate Among Women With High Grade Cervical Dysplasia 10/19/2005 5:13:05 PM    More...
Stressgen Biotechnologies Corporation (SSB.TO) Announces Financial Results 10/19/2005 5:13:01 PM    More...
Stressgen Biotechnologies Corporation (SSB.TO) Files Canadian Amended And Restated Preliminary Prospectus For Offering Of Common Shares 10/19/2005 5:12:51 PM    More...
Stressgen Biotechnologies Corporation (Canada) (SSB.TO) Announces Sale Of Bioreagents Business For Approximately C$8.0 Million And Withdraws Preliminary Prospectus For Offering Of Common Shares 10/19/2005 5:12:50 PM    More...
Stressgen Biotechnologies Corporation (SSB.TO) Completes Enrollment In HspE7 Internal Genital Warts Trial 10/19/2005 5:12:21 PM    More...
Stressgen Biotechnologies Corporation (SSB.TO) Announces Positive Phase II Data In High Grade Cervical Dysplasia 10/19/2005 5:12:14 PM    More...
Stressgen Biotechnologies Corporation (SSB.TO) Granted Additional Patent Covering Use Of Lead Compound, HSPE7 10/19/2005 5:11:23 PM    More...
Stressgen Biotechnologies Corporation (SSB.TO) Announces First Quarter 2004 Financial Conference Call 10/19/2005 5:11:11 PM    More...
Stressgen Biotechnologies Corporation (SSB.TO) Announces First Quarter 2004 Financial Conference Call 10/19/2005 5:11:03 PM    More...
123

//-->